This page collects WhisperX intelligence signals tagged #gene therapy. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
A senior FDA official, speaking anonymously, has revealed that the agency has concluded the experimental Huntington's disease treatment from UniQure provides no therapeutic benefit to patients based on the existing clinical data. This internal assessment directly explains the FDA's decision to block the company from su...
Sarepta Therapeutics is attempting a high-stakes turnaround, with its stock soaring over 20% on the back of promising early clinical data for two new muscular dystrophy drugs. This surge represents a critical vote of confidence from investors, but it comes against the backdrop of a company still reeling from a catastro...
MeiraGTx Holdings plc has filed a significant 8-K form with the SEC, revealing multiple material developments in a single disclosure. The filing, submitted on March 26, 2026, indicates the company has entered into a new definitive agreement and has created a direct financial obligation, signaling active financial and o...
Roche is launching a new clinical trial for its Duchenne muscular dystrophy gene therapy, Elevidys, in a direct response to European regulators who rejected the drug last year. The Swiss pharmaceutical giant announced the move after the European Medicines Agency delivered a negative review, stating the therapy failed t...